Kintor’s Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
- Sunday, January 10, 2021, 7:07
- Finance
- Add a comment
SUZHOU, China, Jan. 10, 2021 /PRNewswire/ — Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr. Andy Goren and Dr. Flávio…
About the Author
adminasapcorp has written 41558 stories on this site.